mexiletine has been researched along with Brachial Paresis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashizume, A; Hijikata, Y; Hirakawa, A; Inagaki, T; Ito, D; Katsuno, M; Kinoshita, F; Kishimoto, Y; Nakamura, T; Shimizu, S; Yamada, S | 1 |
| Hashizume, A; Hijikata, Y; Hirakawa, A; Inagaki, T; Ito, D; Katsuno, M; Kinoshita, F; Kobayashi, Y; Nakamura, T; Nakatochi, M; Yamada, S | 1 |
2 trial(s) available for mexiletine and Brachial Paresis
| Article | Year |
|---|---|
Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial.
Topics: Bulbo-Spinal Atrophy, X-Linked; Humans; Mexiletine; Muscle Weakness; Paresis; Pressure; Tongue | 2022 |
Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS).
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Bulbo-Spinal Atrophy, X-Linked; Cold Temperature; Cross-Over Studies; Double-Blind Method; Drug Monitoring; Humans; Japan; Male; Mexiletine; Middle Aged; Neurologic Examination; Paresis; Treatment Outcome; Voltage-Gated Sodium Channel Blockers | 2018 |